Development and evaluation of targeted liposomes for improved doxorubicin and quercetin delivery for MDR breast cancer
TmAb-DOX-QCT-LIPO demonstrated superior anticancer potential by integrating dual-drug loading, P-gp inhibition, and HER2-targeted uptake, offering a promising therapeutic strategy against MDR breast cancer.
Authors
- Rashmi Maurya (ORCID: https://orcid.org/0000-0001-8496-017X)
- Preeti Patel (ORCID: https://orcid.org/0000-0003-1606-2241)
- Ghanshyam Das Gupta (ORCID: https://orcid.org/0000-0002-5377-1082)
- Balak Das Kurmi (ORCID: https://orcid.org/0000-0001-8470-6622)
- Shreastha Gautam
Institutions
- Indo Soviet Friendship College of Pharmacy (IN)
Publication Details
- Journal
- Therapeutic Delivery
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1080/20415990.2025.2570635
- Citations
- 1
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.60